Skip to main content
SpringerLink
Log in

Thyroid Disorders Associated with Pregnancy

Etiology Diagnosis and Management

  • Therapy in Practice
  • Published:
Treatments in Endocrinology

Abstract

Pregnancy has an effect on thyroid economy with significant changes in iodine metabolism, serum thyroid binding proteins, and the development of maternal goiter especially in iodine-deficient areas. Pregnancy is also accompanied by immunologic changes, mainly characterized by a shift from a T helper-1 (Th1) lymphocyte to a Th 2 lymphocyte state.

Thyroid peroxidase antibodies are present in 10% of women at 14 weeks’ gestation, and are associated with (i) an increased pregnancy failure (i.e. abortion), (ii) an increased incidence of gestational thyroid dysfunction, and (iii) a predisposition to postpartum thyroiditis. Thyroid function should be measured in women with severe hyperemesis gravidarum but not in every patient with nausea and vomiting during pregnancy. Graves hyperthyroidism during pregnancy is best managed with propylthiouracil administered throughout gestation. Thyroid-stimulating hormone-receptor antibody measurements at 36 weeks’ gestation are predictive of transient neonatal hyperthyroidism, and should be checked even in previously treated patients receiving thyroxine. Postpartum exacerbation of hyperthyroidism is common, and should be evaluated in women with Graves disease not on treatment. Radioiodine therapy in pregnancy is absolutely contraindicated.

Hypothyroidism (including subclinical hypothyroidism) occurs in about 2.5% of pregnancies, and may lead to obstetric and neonatal complications as well as being a cause of infertility.

During the last few decades, evidence has been presented to underpin the critical importance of adequate fetal thyroid hormone levels in order to ensure normal central and peripheral nervous system maturation. In iodine-deficient and iodine-sufficient areas, low maternal circulating thyroxine levels have been associated with a significant decrement in child IQ and development. These data suggest the advisability of further evaluation for a screening program early in pregnancy to identify women with hypothyroxinemia, and the initiation of prompt treatment for its correction. Hypothyroidism in pregnancy is treated with a larger dose of thyroxine than in the nonpregnant state.

Postpartum thyroid dysfunction (PPTD) occurs in 50% of women found to have thyroid peroxidase antibodies in early pregnancy. The hypothyroid phase of PPTD is symptomatic and requires thyroxine therapy. A high incidence (25–30%) of permanent hypothyroidism has been noted in these women. Women having transient PPTD with hypothyroidism should be monitored frequently, as there is a 50% chance of these patients developing hypothyroidism during the next 7 years.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Table I
Table II
Table III
Table IV
Table V
Fig. 1
Fig. 2

Similar content being viewed by others

References

  1. Glinoer D. The regulation of thyroid function in pregnancy: pathways of endocrine adaptation from physiology to pathology. Endocr Rev 1997; 18: 871–87

    Article  Google Scholar 

  2. Weetman AP. The immunology of pregnancy. Thyroid 1999; 9: 643–6

    Article  PubMed  CAS  Google Scholar 

  3. Brent GA. Maternal thyroid function: interpretation of thyroid function tests in pregnancy. Clin Obstet Gynecol 1997; 40: 3–15

    Article  PubMed  CAS  Google Scholar 

  4. Glinoer D. Thyroid regulation and dysfunction in the pregnant patient [online]. Available from URL: http://www.thyroidmanager.org [Accessed 2003 Mar 21] 5. Burrow GN, Golden LH. Thyroid disease during pregnancy [online]. Available from URL: http://www.endotext.org [Accessed 2003 Mar 21]

  5. Burrow GN, Golden LH. Thyroid disease during pregnancy [online]. Available from URL: http://www.endotext.org [Accessed 2003 Mar 21]

  6. Caron P, Hoff M, Bazzi S, et al. Urinary iodine excretion during normal pregnancy in healthy women living in the southwest of France: correlation with maternal thyroid parameters. Thyroid 1997; 7(5): 749–54

    Article  PubMed  CAS  Google Scholar 

  7. Elnagar B, Eltom A, Wide L, et al. Iodine status, thyroid function and pregnancy: study of Swedish and Sudanese women. Eur J Clin Nutr 1998; 53: 351–5

    Article  Google Scholar 

  8. Glinoer D. The regulation of thyroid function during normal pregnancy: importance of the iodine nutrition status. Best Pract Res Clin Endocrinol Metab 2004; 18(2): 133–52

    Article  PubMed  CAS  Google Scholar 

  9. Knudsen N, Laurberg P, Perrild H, et al. Risk factors for goiter and thyroid nodules. Thyroid 2002; 12(10): 879–88

    Article  PubMed  Google Scholar 

  10. d’Herbomez M, Forzy G, Gasser F, et al. Clinical evaluation of nine free thyroxine assays: persistent problems in particular populations. Clin Chem Lab Med 2003; 41(7): 942–7

    PubMed  Google Scholar 

  11. Russell AS. Biology of human pregnancy: immune modulation (Th1 and Th2 responses in pregnancy). Scand J Rheumatol 1998; 27: 14–7

    Article  Google Scholar 

  12. Iwatani Y, Amino N, Tachi J, et al. Changes of lymphocyte subsets in normal pregnant and postpartum women: postpartum increase of NK/K (Leu 7) cells. Am J Reprod Immunol Microbiol 1988; 18: 52–5

    PubMed  CAS  Google Scholar 

  13. Szekeres-Bartho J. Immunological relationship between the mother and the fetus. Int Rev Immunol 2002; 21: 471–95

    Article  PubMed  CAS  Google Scholar 

  14. Saito S, Sakai M, Sasaki K, et al. Quantitative analysis of peripheral blood ThO, Th1, Th2 and the Thl: Th2 cell ratio during normal human pregnancy and preeclampsia. Clin Exp Immunol 1999; 117: 550–5

    Article  PubMed  CAS  Google Scholar 

  15. Kincade PW, Medina KL, Payne KJ, et al. Early B-lymphocyte precursors and their regulation by sex steroids. Immunol Rev 2000; 175: 128–37

    Article  PubMed  CAS  Google Scholar 

  16. Davies TF. The thyroid immunology of the postpartum period. Thyroid 1999; 9: 675–84

    Article  PubMed  CAS  Google Scholar 

  17. Hall R. Pregnancy and autoimmune endocrine disease. Baillieres Clin Endocrinol Metab 1995; 9: 137–55

    Article  PubMed  CAS  Google Scholar 

  18. Elenkov IJ, Wilder RL, Bakalov VK, et al. IL-12, TNF-α, and hormonal changes during late pregnancy and early postpartum: implications for autoimmune disease activity during these times. J Clin Endocrinol Metab 2001; 86: 4933–8

    Article  PubMed  CAS  Google Scholar 

  19. Kim CH, Chae HD, Kang BM, et al. Influence of antithyroid antibodies in euthyroid women on in vitro fertilization-embryo transfer outcome. Am J Reprod Immunol 1998; 40: 2–8

    Article  PubMed  CAS  Google Scholar 

  20. Mecacci F, Parretti E, Cioni R, et al. Thyroid autoimmunity and its association with non-organ-specific antibodies and subclinical alterations of thyroid function in women with a history of pregnancy loss or pre-eclampsia. J Reprod Immunol 2000; 46: 39–50

    Article  PubMed  CAS  Google Scholar 

  21. Bussen S, Steck T, Dietl J. Increased prevalence of thyroid antibodies in euthyroid women with a history of recurrent in-vitro fertilization failure. Hum Reprod 2002; 15: 545–8

    Article  Google Scholar 

  22. Abramson J, Stagnaro-Green A. Thyroid antibodies and fetal loss: an evolving story. Thyroid 2001; 11: 57–63

    Article  PubMed  CAS  Google Scholar 

  23. Lazarus JH, Kokandi A. Thyroid disease in relation to pregnancy: a decade of change. Clin Endocrinol 2000; 53(3): 265–78

    Article  CAS  Google Scholar 

  24. Rodien P, Bremont C, Sanson ML, et al. Familial gestational hyperthyroidism caused by a mutant thyrotropin receptor hypersensitive to human chorionic gonadotropin. N Engl J Med 1998; 339(25): 1823–6

    Article  PubMed  CAS  Google Scholar 

  25. Baloch Z, Carayon P, Conte-Devolx B, et al. Laboratory medicine practice guidelines: laboratory support for the diagnosis and monitoring of thyroid disease. Thyroid 2003; 13(1): 3–126

    Article  PubMed  Google Scholar 

  26. Maziukiewicz UR, Burrow GN. Hyperthyroidism in pregnancy, diagnosis and treatment. Thyroid 1999; 9(7): 647–52

    Article  Google Scholar 

  27. Millar LK, Wing DA, Leung AS, et al. Low birth weight and pre-eclampsia in pregnancies complicated by hyperthyroidism. Obstet Gynecol 1994; 84: 946–9

    PubMed  CAS  Google Scholar 

  28. Hamburger JI. Diagnosis and management of Graves’ disease in pregnancy. Thyroid 1992; 2: 219–24

    Article  PubMed  CAS  Google Scholar 

  29. Kung AWC, Jones BM. A change from stimulatory to blocking antibody activity in Graves’ disease during pregnancy. J Clin Endocrinol Metabol 1998; 83: 514–8

    Article  CAS  Google Scholar 

  30. Zakarija M, De Forteza R, McKenzie JM, et al. Characteristics and clinical correlates of a novel thyroid-stimulating autoantibody. Autoimmunity 1994; 19(1): 31–7

    Article  PubMed  CAS  Google Scholar 

  31. Mestman JH. Hyperthyroidism in pregnancy. Endocrinol Metab Clin North Am 1998; 27: 127–49

    Article  PubMed  CAS  Google Scholar 

  32. Laurberg P, Nygaard B, Glinoer D, et al. Guidelines for TSH-receptor antibody measurements in pregnancy: results of an evidence-based symposium organized by the European Thyroid Association. Eur J Endocrinol 1998; 139(6): 584–6

    Article  PubMed  CAS  Google Scholar 

  33. Zanzonico PB, Becker DV. Radiation hazards in children born to mothers exposed to 131-iodine. In: Beckers C, Reinwein D, editors. The thyroid and pregnancy, international MERCK symposium. Brussels: Schattauer, 1991: 189–202

    Google Scholar 

  34. Mandel SJ, Cooper DS. The use of antithyroid drugs in pregnancy and lactation. J Clin Endocrinol Metab 2001; 86: 2354–9

    Article  PubMed  CAS  Google Scholar 

  35. Karlsson FA. Severe embryopathy and exposure to methimazole in early pregnancy. J Clin Endocrinol Metab 2002; 87(2): 947–9

    Article  PubMed  CAS  Google Scholar 

  36. Hashizume K, Ichikawa K, Nishii Y, et al. Effect of administration of thyroxine on the risk of postpartum recurrence of hyperthyroid Graves’ disease. J Clin Endocrinol Metab 1992; 75: 6–10

    Article  PubMed  CAS  Google Scholar 

  37. Gonzalez-Jimenez A, Fernandez-Soto ML, Escobar-Jimenez F, et al. Thyroid function parameters and TSH-receptor antibodies in healthy subjects and Graves’ disease patients: a sequential study before, during and after pregnancy. Thyroidology 1993; 5: 13–20

    PubMed  CAS  Google Scholar 

  38. Lazarus JH, Ludgate ME. Prevention and treatment of postpartum Graves’ disease. Baillieres Clin Endocrinol Metab 1997; 11(3): 549–60

    Article  PubMed  CAS  Google Scholar 

  39. Klein RZ, Haddow JE, Faixt JD, et al. Prevalence of thyroid deficiency in pregnant women. Clin Endocrinol 1991; 35: 41–6

    Article  CAS  Google Scholar 

  40. Morreale de Escobar G, Obregon MJ, del Rey F. Is neuropsychological development related to maternal hypothyroidism or to maternal hypothyroxinemia? J Clin Endocrinol Metab 2000; 85: 3975–87

    Article  Google Scholar 

  41. Alexander EK, Marqusee E, Lawrence J, et al. Timing and magnitude of increases in levothyroxine requirements during pregnancy in women with hypothyroidism. N Engl J Med 2004; 351(3): 241–9

    Article  PubMed  CAS  Google Scholar 

  42. Chin WW, Yen PM. Molecular mechanisms of nuclear thyroid hormone action. In: Braverman LE, editor. Diseases of the thyroid. Totowa (NJ): Humana Press Inc., 2003: 1–19

    Google Scholar 

  43. Bernai J. Action of thyroid hormone in brain. J Endocrinol Investig 2002; 25: 268–88

    Google Scholar 

  44. Haddow JE, Palomaki GE, Allan WC, et al. Maternal thyroid deficiency during pregnancy and subsequent neuropsychological development of the child. N Engl J Med 1999; 341: 59–55

    Article  Google Scholar 

  45. Pop VJ, Kuijpens JL, van Baar AL, et al. Low maternal free thyroxine concentrations during early pregnancy are associated with impaired psychomotor development in infancy. Clin Endocrinol 1999; 50: 147–8

    Article  Google Scholar 

  46. Pop VJ, de Vries E, van Baar AL, et al. Maternal thyroid peroxidase antibodies during pregnancy: a marker of impaired child development? J Clin Endocrinol Metab 1995; 80: 3561–6

    Article  PubMed  CAS  Google Scholar 

  47. Man EB, Serunian SA. Thyroid function in human pregnancy: IX. Development or retardation of 7-year-old progeny of hypothyroxinemic women [abstract]. Am J Obstet Gynecol 1976; 125: 949

    PubMed  CAS  Google Scholar 

  48. Hay I. Nodular thyroid disease diagnosed during pregnancy: how and when to treat. Thyroid 1999; 9(7): 667–70

    Article  PubMed  CAS  Google Scholar 

  49. Choe W, McDougall IR. Thyroid cancer in pregnant women: diagnostic and therapeutic management. Thyroid 1994; 4: 433–5

    Article  PubMed  CAS  Google Scholar 

  50. Schlumberger M, De Vathaire F, Ceccarelli C,et al. Exposure to radioactive iodine-131 scintigraphy or therapy does not preclude pregnancy in thyroid cancer patients. J Nucl Med 1996; 37: 612–5

    Google Scholar 

  51. Lazarus JH, Hall R, Othman S, et al. The clinical spectrum of postpartum thyroid disease. QJM 1996; 89: 429–35

    Article  PubMed  CAS  Google Scholar 

  52. Muller AF, Drexhage HA, Berghout A. Postpartum thyroiditis and autoimmune thyroiditis in women of childbearing age: recent insights and consequences for antenatal and postnatal care. Endocr Rev 2001; 22: 605–30

    Article  PubMed  CAS  Google Scholar 

  53. Lazarus JH, Premawardhana LD, Parkes AB. Postpartum thyroiditis. Autoimmunity 2002; 35: 169–73

    Article  PubMed  CAS  Google Scholar 

  54. Wass J, Shalet S, editors. Oxford textbook of endocrinology. Oxford: Oxford University Press, 2002

    Google Scholar 

  55. Premawardhana LD, Parkes AB, Ammari F, et al. Postpartum thyroiditis and long-term thyroid status: prognostic influence of thyroid peroxidase antibodies and ultrasound echogenicity. J Clin Endocrinol Metab 2000; 85: 71–5

    Article  PubMed  CAS  Google Scholar 

Download references

Acknowledgments

The author has received no funding to assist in the preparation of this review and has no conflicts of interest that are directly relevant to the content of this review.

Author information

Authors and Affiliations

  1. Department of Medicine, University of Wales College of Medicine, Heath Park, Cardiff, CF14 4XN, UK

    John H. Lazarus

Authors
  1. John H. Lazarus
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to John H. Lazarus.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Lazarus, J.H. Thyroid Disorders Associated with Pregnancy. Mol Diag Ther 4, 31–41 (2005). https://doi.org/10.2165/00024677-200504010-00004

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.2165/00024677-200504010-00004

Keywords

Search

Navigation